abstract |
The present invention describes a novel single drug entity formed by direct binding of an antibiotic to a steroid drug. Upon topical application to the eye, the conjugate undergoes enzymatic and / or hydrolytic cleavage to release individual drugs. The antibiotic is directly bound to the steroid drug. [Selection] Figure 1 |